Como, Italy

Francesco Scarci

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Polichem S.a.. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Francesco Scarci. Retrieved from https://idiyas.com/inventor/francesco-scarci

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Francesco Scarci: Innovator in Gastrointestinal Treatments

Introduction

Francesco Scarci is a notable inventor based in Como, Italy. He has made significant contributions to the field of medicine, particularly in the treatment of gastrointestinal disorders. His innovative approach has led to the development of a unique treatment for irritable bowel syndrome.

Latest Patents

Francesco Scarci holds a patent for the use of pidotimod to treat irritable bowel syndrome. The present invention is directed to the use of pidotimod, or a physiologically acceptable salt thereof, to treat this condition. For the treatment, pidotimod may be administered either by oral route or rectally. This patent highlights Scarci's commitment to improving patient care through innovative solutions.

Career Highlights

Scarci is associated with Polichem S.a., a company that focuses on developing pharmaceutical products. His work at Polichem has allowed him to explore and implement groundbreaking treatments that address pressing health issues. With 1 patent to his name, Scarci has established himself as a key figure in the medical innovation landscape.

Collaborations

Some of his notable coworkers include Federico Mailland and Maurizio Caserini. Their collaboration has contributed to the advancement of research and development within the company.

Conclusion

Francesco Scarci's work exemplifies the impact of innovation in medicine, particularly in treating irritable bowel syndrome. His contributions continue to pave the way for future advancements in gastrointestinal treatments.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…